Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

naloxegol

naloxegol
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Movantik TABLET, ORAL 12.5 mg, 25 mg      
Comments:

Movantik medication guide

 

Pharmacists should discontinue naloxegol when opiates are discontinued.

Reviewed: 22 Sept 2015 (Movantik)

Updated: April 2022 (Restrictions removed)

Last updated: Apr. 29, 2022






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved